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Summary 
• Clinical Performance Indicators for ambulance services should be developed in 
line with best evidence, in partnership with clinicians and service users, and 
linked to national structures for knowledge and evidence, clinical expertise and 
research and development. Their development should be guided by a 
performance monitoring protocol.  
 
• Clinical Performance Indicators for ambulance services should be meaningful, 
measurable and realistic, aiming to address issues that matter to patients and 
clinicians, to benchmark performance, to reduce variations within and between 
health services and to bring about improvements in care for patients and users. 
Indicators should function as part of a planned clinical quality improvement 
framework that draws on modern improvement principles, methods, tools and 
techniques. 
 
• Clinical Performance Indicators for ambulance services should be designed to 
provide safe, effective, patient centred, timely, efficient and equitable healthcare. 
Importantly, they should support clinicians and services in providing better care to 
their patients.  
 
• Resources should be made available to trusts to undertake such measurements, 
to contribute to the national data set, to participate in future development and to 
deliver the aims of quality improvement.  
Introduction  
A performance indicator is an assessment tool used to monitor and evaluate 
important governance, management, clinical, and support functions that affect patient 
outcomes (Joint Commission on Accreditation of Healthcare Organizations 1992). A 
performance indicator can be used to signal successes and deficiencies in quality of 
care, to monitor continuing performance of organisations and to measure the result of 
process improvement. High quality care is safe (no needless harm), effective 
(evidence-based), patient centred (no feelings of helplessness and in accordance 
with patients reasonable expressed wishes), timely (no needless delay), efficient (no 
waste and with realistic outcomes) and equitable (fair to all patients). 
 
Performance indicators are usually based on either rates measured in defined 
populations or on significant (critical) incidents. Indicators can measure structures, 
processes or outcomes of health care (Donabedian 1966). Although process 
measures are often more sensitive to changes in the quality of care (Rubin et al. 
2001b; Rubin et al. 2001a; Mant 2001), intermediate outcomes (i.e. process 
measures which are known to have an effect on the true outcome, for example 
aspirin or thrombolysis in acute myocardial infarction) are appropriate and often 
superior to simple process measures, e.g. ECG capture in acute myocardial 
infarction (AMI).  
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This paper seeks to describe the principles, rationale and process for developing 
Clinical Performance Indicators (CPIs) for quality improvement in ambulance and 
unscheduled (prehospital) care suitable for one or more services. Indicators will 
depend to some extent on geographical and resource considerations as well as 
outcomes (MacFarlane and Benn 2003).  
 
A number of widely accepted terms are used in the paper. Criteria are “the elements 
of care that can be counted or measured in order to assess quality” (Donabedian 
1982). Standards are “the precise count or quantity (of criteria) that specify an 
acceptable level of care” (Donabedian 1980). Guidelines or clinical practice 
guidelines are “systematically developed statements to assist practitioner and patient 
decisions about appropriate health care for specific clinical circumstances” (Effective 
Health Care 1994). Quality improvement is arguably a better term than clinical audit 
because it describes what is intended as an outcome of the process of development 
of Clinical Performance Indicators and is less liable to be confused with simply 
counting events which can be frustratingly ineffective at bringing about change 
(Thomson O'Brien et al. 2000a). There are few validated clinical measures of 
effectiveness and quality in prehospital care that have been used nationally (Moore 
1999) and this is partly due to the absence of a clear and agreed process for their 
development.  
 
This discussion paper provides the basis for a detailed protocol for future 
development of ambulance service Clinical Performance Indicators. (Working Party 
on Performance Monitoring in the Public Services 2005) 
Principles underlying Clinical Performance Indicator development  
In developing a set of indicators a number of principles need to be considered 
(MacKinnon and McCaffrey 2004). The basis for this should be the recognition that 
‘every system is perfectly designed to get the results it achieves’ (Nolan 1998); put 
another way ‘if you do what you did you’ll get what you got’.  
 
♦ The performance measurement system must be linked to health strategies and 
take a systems approach  
♦ Broad stakeholder consultation is required in developing indicators (Tregunno et al. 
2004) 
♦ Indicators should demonstrate how decisions are made and priorities are 
determined 
♦ Indicators should take into account the impact of their adoption on health 
♦ Incentives (not necessarily financial) are needed for ongoing innovation  
♦ Resources are required to create the infrastructure for improvement 
♦ There is a role for better practices and benchmarking measurement even when 
comprehensive information is not available.  
 
Such principles have formed the basis for development of indicators in North America 
(Sobo et al. 2001) and some elements have been included in early developments in 
this area in the United Kingdom (The Joint ASA JRCALC Clinical Effectiveness 
Programme 2005). 
Development of Clinical Performance Indicators 
Clinical Performance Indicators (CPIs) should be based on ‘review criteria’ which are 
rate based quality improvement measures defined as ‘systematically developed 
statements that can be used to assess the appropriateness of specific healthcare 
decisions, services and outcomes’ (Hearnshaw et al. 2001). 
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CPIs need to be:  
♦ Relevant, meaningful and practicable. 
♦ Precisely defined, clear and unambiguous preventing rather than encouraging 
perverse behaviours. 
♦ Consistent over time ideally but if a change is needed this should be clearly 
documented. 
♦ Limited in number particularly when comparing teams and services, these will be 
critical clinical performance indicators (CCPIs). 
♦ Based on evidence or evidence informed clinical experience that their use will lead 
to patient benefit – the level of evidence needs to be clearly stated. 
♦ Goal-orientated for health gain in terms of clinical process and outcomes (both 
positive and negative), patient outcomes (such as patient satisfaction) and 
economic outcomes 
♦ Assessed against their usefulness in comparing performance, reducing variation 
and improving care  
♦ Excluded from measurement when they are no longer seen to be useful. 
♦ Cognisant of geographical (time to nearest hospital) and resource (clinical 
attending) factors as well as outcomes such as hospital admission, morbidity and 
survival including post-discharge and longer term outcomes. 
♦ Acceptable and understandable for clinicians. 
♦ Cost-effective in terms of value for money in collecting and analysing data in 
relation to potential benefits.   
 
Criteria can be derived from:  
♦ Current national guidelines, e.g. JRCALC (Joint Royal Colleges Ambulance Liaison 
Committee and Ambulance Service Association 2006), NICE (National Institute for 
Health and Clinical Excellence), NSFs (National Service Frameworks) etc.  
♦ Robust research evidence including systematic reviews, e.g. Cochrane reviews 
 
There are a number of other factors that are likely to ensure that the criteria or 
indicators chosen will lead to benefit. These are summarised by the following 
questions (Hearnshaw et al. 2002):  
1.1 Were the quality improvement criteria based on the following?  
(a) Searching the research literature? 
(b) Consultation with experts? 
(c) Consultation with patients or carers? 
(d) Criteria used in previous quality improvements? 
1.2  
(a) How up to date was the literature review? 
Was the following information recorded (by you or the authors of the review): 
(b) The sources/databases used to identify the literature? 
(c) Whether the validity of the research was appraised? 
(d) The methods used to assess validity? 
1.3 Is the method of combining evidence from the literature and expert opinion made 
explicit? 
1.4 Is the method used to select the quality improvement criteria described in enough 
detail to be repeated? 
1.5 Were the quality improvement criteria pilot tested for practical feasibility? 
1.6 Were the quality improvement criteria prioritised on: 
(a) Impact on health outcome? 
(b) Quality of supporting evidence? 
1.7 Were the relative values of harms and benefits associated with treatment options 
considered in selecting criteria? 
2.1 Do the criteria: 
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(a) State the patient populations to which they apply? 
(b) State the clinical settings to which they apply? 
(c) Give clear definitions of the variables to be measured? 
(d) Use unambiguous terms? 
2.2 Are the criteria linked to improving health outcomes (rather than, say, to reducing 
costs or increasing throughput)? 
2.3 Do the criteria enable you to differentiate between appropriate and inappropriate 
care? 
3.1 Did the criteria have information on: 
(a) How the demands of the quality improvement on patients might be minimised? 
(b) How the demands of the quality improvement on staff might be minimised? 
3.2 Did the criteria have clear instructions for using them? 
3.3 Were patients consulted about the acceptability of these criteria for them? 
3.4 Were staff consulted about the acceptability of these criteria for them? 
 
By scoring criteria on the questions above giving 1 to each ‘Yes’ response, 0.5 for 
‘Partly’ and 0 for ‘No’ and ‘Don’t know’ we can get a measure of the usefulness of the 
criterion as part of a Clinical Performance Indicator.  
Implementing and Measuring Change  
For change to occur it is not enough to provide written guidance alone (Freemantle et 
al. 2000) or passive methods to individuals or teams (Grimshaw et al. 2001). It is the 
front line clinicians that have the clinical knowledge, ability and power to improve the 
care for patients (the ‘inverted pyramid’) and there is ample evidence that this is the 
key priority for clinical staff (Ham 2003). We therefore need to systematically ensure 
the following: 
♦ We need to begin with existing well tried-and-tested criteria to ensure that the 
process is understood and owned by clinicians and clinical leaders.  
♦ Indicators should be assessed initially and regularly thereafter for appropriateness 
with patients and staff. This will enable staff and patients to have ownership of this 
information and the processes that are likely to lead to improvement 
♦ Indicators should have the potential to exhibit, or identify, change within a planned 
timescale which requires prior assessment of how much improvement it is plausible 
to achieve within the timescale, taking account of research evidence, local 
initiatives, organizational culture, resources and ceiling effects. 
♦ Target or standard setting should take account prior (or emerging) knowledge 
about essential variation. 
♦ A simple risk assessment should undertaken at the outset to predict possible 
adverse or perverse outcomes relating to specific criteria.  
♦ Resources for quality improvement should be identified – a key resource is the 
clinical time required to feed into the process and to bring about change. 
Resources should be made available to trusts to undertake such measurements, to 
contribute to the national data set, to participate in future development and to 
deliver the aims of quality improvement. Previous failures have been a 
consequence of underinvestment in this area.  
♦ New indicators should be piloted before full release and adoption. 
♦ Information should ideally be fed (as close to real time as possible) to the quality 
improvement team by or on behalf of small organisational units or teams and the 
performance of such teams against agreed standards made immediately available 
to teams and team leaders so that they can identify how their team is performing, 
how individual members of the team are contributing to this performance, whether 
there is any shortfall in performance compared to the standards set and whether 
any support needs to be provided to an individual to the team as a whole.  
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♦ Comparative feedback needs to be provided in a timely way to support 
improvement measures. 
♦ In order to show real differences between units, robust techniques, for example 
confidence charts (funnel plots or trombonograms), should be utilised which show 
real differences between teams or geographical areas (Simpson et al. 2005) and 
enable excellent practice to be shared between high performing and 
underperforming units, whether formally or informally. 
♦ Educational support should be engaged to link in with teams who are performing 
very well and those who are performing less well in order to undertake diagnostic 
assessment and share good practice to support teams. 
♦ Educational interventions (this refers to education in its broadest sense) should be 
designed to be provide active (rather than passive) education which should be 
tailored to overcome barriers to change (Baker et al. 1999) and delivered locally or 
service wide depending on the nature of the issue using local opinion leaders and 
clinical leaders to encourage and effect change (Thomson O'Brien et al. 2000b).  
♦ Comparative feedback should be made openly available and shared with Clinical 
Teams, Education Specialists and the Trust Board and Executive in a supportive 
way.  
♦ In order to accurately demonstrate change, careful analysis (Working Party on 
Performance Monitoring in the Public Services 2005) robust techniques, such as 
statistical process control or interrupted time series methods, for demonstrating real 
improvement over time should be used (Balestracci 2006; Benneyan et al. 2003). 
♦ High performing teams and those showing real improvement should be recognised 
and rewarded. 
 
These techniques have already been used to bring about and measure real 
improvements in prehospital care (Siriwardena 2006). 
Features required of Clinical Performance Indicators (CPIs) 
The following questions should therefore be asked about CPIs (MacKinnon 1998): 
 
1. Are the performance measures reliable, valid, and feasible to use? If previously 
validated measures are chosen, were they designed to be used on individual patients 
or at a population-based level of analysis? 
2. Can the data needed for the performance measures be easily obtained from 
existing sources of information or will it require additional resources and pose an 
additional burden on patient care? If ideal data is too hard to collect, is there similar 
data existing already somewhere in the flow of care? 
3. Are there performance measures for all the key structures, processes, and 
outcomes? 
4. Can the performance measures chosen be used for other purposes within the 
organization? 
5. Have performance measures been developed for each step of the management of 
disease? 
6. Do the performance measures need to be severity-adjusted?  
7. What is the target for each performance measure? Is there a benchmark 
available? How will statistical significance versus clinical significance be determined 
when the performance measure data is analysed? 
8. Would sentinel or rate-based performance measures be more appropriate? 
 
Clinical domains should relate to:  
♦ Impact (incidence/hospitalisation/cost) 
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♦ Potential for improved outcomes (prevention of intermediate or true outcome/ 
reduction in morbidity or improvement of true outcome/improved user/patient or 
carer experience) 
♦ Comparative performance within service (comparing clinical teams or geographical 
areas) or between services  
 
In order to derive appropriate indicators the following reviews of primary and 
secondary evidence would provide a good starting point:  
♦ JRCALC guidelines 
♦ NICE and SIGN guidance and National Service Framework recommendations 
related to prehospital care 
♦ Prehospital and emergency care literature for primary evidence 
Clinical Performance Indicator categories 
Indicators could be categorised in various ways to form a coherent set that measures 
quality across a range of clinical issues. The following three categories could be 
employed and examples (not comprehensive) of specific areas are shown:  
Clinical Syndrome/Presentation Indicators (CSPIs), e.g.  
♦ Trauma including head injury 
♦ Pain 
♦ Cardiac arrest 
♦ Hypoglycaemia 
♦ Major incidents 
♦ Falls 
♦ ECP 
Clinical Disease Indicators (CDIs), e.g. 
Coronary Heart Disease 
Stroke  
Diabetes Mellitus/Hypoglycaemia  
Asthma 
Chronic Obstructive Pulmonary Disease 
Overdose 
Clinical Related Indicators (CRIs), e.g. 
Record keeping 
Clinical communication 
Patient communication and consent 
Education & training 
Medicines management 
Infection control 
Patient experience 
Clinical Performance Indicator format 
The format for CPIs should be defined to promote ease and consistency of use within 
and across services. Although many ambulance services use similar CPIs the 
detailed definition, sampling strategy, exceptions and targets vary.  
 
The most commonly used format in the United Kingdom is as follows:  
An indicator is made up of 4 components: 
• Aspect of care. The area of documentation that is being examined which may 
be basic (date) or more specific (administration of a drug) 
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• The standard. This is often set at 100% but the appropriateness of this needs 
to be examined in light of common cause or natural variation. 
• Exceptions. This could be a contraindication or the state of the patient (unable 
to administer a drug as the patient was unconscious) 
• Definitions and Instructions – This is the source or basis for the aspect of care 
such as a protocol, guideline, or evidence based practice.. 
Using aspirin administration as an example, an aspect of care is either compliant (Y) 
which means there is documentation, of aspirin administration.  Not compliant (N) 
which means there is no record of aspirin administration, or that there is no 
documentation of an exception. Or lastly, there was an exception (E) in this case that 
there was documentation that there was a contraindication, the patient was 
unconscious, the patient refused, or the patient had already taken their own aspirin 
before the crew arrived. 
 
Another more detailed format for emergency performance indicators has been 
developed and approved by the Open Source Emergency Service (EMS) initiative in 
the United States. 
 
The format is as follows [Performance Indicator Format (version 060103)]: 
♦ Indicator Name – Name or title of the performance indicator 
♦ Key Process Path – Starting with one of the predefined key process names, this 
item shows which key process and sub-process that the indicator reflects on 
♦ Patient or Customer / Need – Indicators are designed to reflect on how well and/or 
how efficiently a given patient or customer need is being met. This item shows what 
patient or customer / need that the indicator reflects on 
♦ Type of Measure – Structure, process or outcome 
♦ Objective – Describes why an indicator is useful in specifying and assessing the 
process or outcome of care measured by the indicator 
♦ Indicator Formula – The equation for calculation of the indicator. If applicable, 
separate sections will separately address the numerator and denominator of the 
indicator equation. 
♦ Indicator Formula Description – Explanation of the formula used for the indicator. 
Where applicable, separate descriptions detailing the numerator and denominator 
will be provided. 
o Denominator Description – Description of the population being studied or 
other denominator characteristics, including any equation or other key 
aspects that characterize the denominator 
o Denominator Inclusion Criteria – Additional information not included in the 
denominator statement that details the parameters of the denominator 
population 
o Denominator Exclusion Criteria – Information describing criteria for 
removing cases from the denominator 
o Denominator Data Sources – Sources for data used in generating the 
denominator 
o Numerator Description– Description of the subset of the population being 
studied or other numerator characteristics, including any equation or other 
key aspects that characterize the numerator 
o Numerator Inclusion Criteria – Additional information not included in the 
numerator statement that details the parameters of the numerator population 
o Numerator Exclusion Criteria – Information describing criteria for removing 
cases from the numerator 
o Numerator Data Sources – Sources for data used in generating the 
numerator 
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♦ Sampling Allowed – Indicates if sampling the study population is or is not allowed in 
calculation of this indicator. 
♦ Sampling Description – If sampling is allowed, this will describe the sampling 
process to be used for this indicator. 
♦ Minimum Number of Data Points – Tells how many data points are needed, at a 
minimum, for calculation of this indicator. 
♦ Suggest Reporting Format: Numerical – The suggested way in which the numerical 
results should be expressed (i.e. decimal minutes, percentages, ratios) 
♦ Suggest Reporting Format: Graphical – The suggested way in which reports should 
be presented in graphical format (i.e. pie charts, statistical process control charts, 
etc.) 
♦ Suggest Reporting Frequency – Time frame, number of successive cases or other 
grouping strategies by which cases should be aggregated for calculating and 
reporting results 
♦ Testing – Indicates if a formal structured evaluation has been performed on the 
various scientific properties of the indicator such as its reliability, validity, and 
degree of difficulty of data collection 
♦ Stratification – Indicates if stratification has been applied to the indicator 
♦ Stratification Options – Suggested stratification criteria for use with this indicator 
♦ Current Development Status – Describes the amount of work completed to date 
relative to the final implementation of the indicator 
♦ Additional Information – Further information regarding an indicator not addressed in 
other sections 
♦ References – Citations of works used for development of the indicator 
♦ Contributors – Listing of persons or organizations used in development and 
refinements to this indicator  
 
Although there are advantages to using a familiar and simple system there are 
aspects of this system that may enhance current methods of defining indicators. 
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Examples of Ambulance Clinical Performance Indicators in current use     
Indicator Category Denominator Type of measure Exceptions References 
and Indicator Name Inclusion 
group (whole 
population if 
not stated) 
Structure Process Intermediate (proxy) 
outcome 
Numerator 
exclusion 
criteria 
Evidence for 
criteria or 
standards 
Clinical Syndrome/Presentation Indicators  
Trauma including head injury    Written head injury 
instructions given  
 (JRCALC 2006) 
Pain  Verbal or visual pain 
score (PRF) 
Initial pain score  
Post-treatment pain score  
Analgesia given 
 
Appropriate analgesia (opiate 
for fracture, AMI) 
Extent of reduction in pain 
score 
Unconscious (JRCALC 2006) 
Cardiac arrest Adult European 
Resuscitation 
Guidelines training 
Automated external 
defibrillator (AED)  
GCS/AVPU 
ECG monitored/rhythm 
Cannulation 
Oxygen 
Intubation 
Recovery of sinus rhythm  
Level of conscious (Glasgow 
coma scale) on admission  
Recognition of 
Life Extinct 
(JRCALC 2006) 
(Hassan et al. 
1996) 
Falls   Falls assessment Referral to 
falls pathway 
Home management  
 
 (JRCALC 2006) 
Major incidents   Response within agreed 
timeframe 
   
Convulsions   GCS/AVPU 
Blood glucose 
SpO2 
Oxygen 
Rectal diazepam (single 
appropriate dose only) 
Glucose 10% IM if 
hypoglycaemic 
 (Chin et al. 2004) 
(JRCALC 2006) 
Safeguarding children  Children   Referral to social services 
when suspected abuse 
 (JRCALC 2006) 
Emergency Care Practitioner (ECP)  ECP attendances   Transported 
A&E attendance  
  
Copyright © 2007 AN Siriwardena. All materials are protected by copyright law. Access to these materials is for the sole purpose of personal educational and research use only. Any use or 
distribution for commercial purposes is expressly forbidden. 
 
 
Indicator Category 
and Indicator Name 
Denominator 
Inclusion 
group (whole 
population if 
not stated) 
Type of measure Exclusions 
Numerator 
exclusion 
criteria 
References 
Evidence for 
criteria or 
standards 
Structure Process Intermediate (proxy) 
outcome 
Clinical Disease Indicators  
Suspected AMI   Oxygen 
Cannulation 
Initial pain score  
Nitrate  
Post-treatment pain score  
Thrombolysis protocol adhered 
to  
Call to admission time 
Opiate 
Aspirin 
Thrombolysis (Chase et al. 
2006) 
Reduction in pain score 
Lives saved per 1000 patients 
(Norris 2001) 
 (JRCALC 2006) 
 
Stroke   FAST test (PRF) Conscious level (GCS/AVPU) 
BP 
FAST 
Glucose 
Oxygen  
Admission for assessment   (JRCALC 2006) 
Asthma   Conscious level  
Pulse 
Initial respiratory rate (RR) 
Post-treatment RR 
Initial PEFR  
Initial pulse oximetry (SpO2) 
Post-treatment PEFR 
Post-treatment SpO2 
Oxygen 35% 
Salbutamol  
Post-treatment PEFR 
improvement 
Post-treatment pulse oximetry 
(SpO2) improvement 
Prednisolone given (ECP) 
 (JRCALC 2006) 
(Snooks et al. 
2005) 
Chronic Obstructive Pulmonary 
Disease 
  Pulse 
Respiratory rate 
SpO2 
Initial PEFR 
Post-treatment PEFR 
Oxygen 28% 
Salbutamol  
Post-treatment pulse oximetry 
(SpO2) improvement 
 (JRCALC 2006) 
(Durrington et al. 
2005)  
Overdose   GCS/AVPU 
Mental state/suicide risk 
Blood glucose 
   
Anaphylaxis   GCS/AVPU 
BP 
Oxygen 35% 
Adrenaline IM 
Chlorphenamine IV 
 (JRCALC 2006) 
Diabetes Mellitus/Hypoglycaemia   GCS/AVPU 
Initial blood glucose 
Glucagon or glucose 
Post-treatment blood glucose 
Urine ketones if glucose 
elevated 
Glucose 10% IV 
 
 (JRCALC 2006) 
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Indicator Category Denominator: 
Inclusion 
group (whole 
population if 
not stated) 
Type of measure Exclusions: 
Numerator 
exclusion 
criteria 
References: 
Evidence for 
criteria or 
standards 
and Indicator Name Structure Process Intermediate (proxy) 
outcome 
Clinical Related Indicators       
Record keeping   PRF completion     
Clinical communication   Handover   (Thakore and 
Morrison 2001) 
Patient communication and consent   Patient satisfaction    
Education & training   Appraisal  
Personal development plan  
   
Medicines management  Policy 
Adverse event 
monitoring 
Prescribing 
monitoring  
    
Infection control  Training      
Patient experience    Satisfaction survey   
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Conclusion 
Evidence is sparse for many CPIs in the prehospital setting. Previous attempts at developing 
national ambulance CPIs have failed through lack of resources. In order to improve stakeholder 
(public, practitioner and organisational) confidence in prehospital care, urgent work to develop 
CPIs further needs to be done. A pragmatic approach would be to select indicators on the basis of 
current evidence and good practice according to a clear and agreed performance monitoring 
protocol. Indicators selected and based on National Service Frameworks or other nationally 
accepted guidance should be investigated in terms of data collection, analysis, resources required 
and potential for quality improvement under the guidance of the national structures being set up for 
clinical knowledge, research and development and clinical quality improvement in ambulance 
services. The principles outlined in this paper should inform development of such as protocol.  
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